期刊文献+

伐昔洛韦与甲钴胺联用治疗复发性生殖器疱疹疗效观察

The clinical value of valaciclovir and mecobalamin for recurrent genital herpes
下载PDF
导出
摘要 目的探讨伐昔洛韦与甲钴胺联用治疗复发性生殖器疱疹的临床应用价值。方法回顾性分析我科治疗的96例复发性生殖器疱疹患者,按照用药方式的不同将患者分为观察组和对照组,其中观察组采取口服伐昔洛韦片和肌注甲钴胺,对照组采取口服伐昔洛韦。30 d观察后两组局部病变的愈合时间以及复发情况。结果观察组患者较对照组在治疗效果、复发率上有明显差异,两组差异具有统计学意义(P<0.05),复发时观察组皮损面积小于对照组,且止疱时间、结痂时间均短于对照组,两组差异具有统计学意义(P<0.01)。结论伐昔洛韦与甲钴胺联用治疗复发性生殖器疱疹具有良好的疗效,值得推广使用。 Objective To explore the clinical value of Valaciclovir and Mecobalamin for recurrent genital herpes. Methods A total of 96 patients were randomly divided into the observational group and the control group according to the diftbrent ways of administration. The control group was given valaciclovir, while the experimental group was given valaciclovir and mecobalamin. Compared the two groups on patients' healing time and the thing of recurrence after 30 days. Results The observation group in healing time and recurrence were better than those in the control group, the difference was statistical- ly significant (P 〈 0.05). The lesion of observation group were smaller than that of the control group when recurrence, and heal ing time was shorter than that of the control group, the difference was statistically significant (P 〈 0.05). Conclusion There a good clinical value of Valaciclovir and Mecobalamin for the treatment of recurrent genital heroes, worthy of !9oDularizing.
作者 潘武辉
出处 《中国现代医生》 2012年第29期72-73,共2页 China Modern Doctor
关键词 复发性生殖器疱疹 甲钴胺注射液 伐昔洛韦 Recurrent genital herpes Mecobalamin Valaciclovir
  • 相关文献

参考文献6

二级参考文献23

  • 1田中伟,宋向凤,冯捷.不同病程生殖器疱疹患者外周血Th1/Th2亚群分布的变化及其临床意义[J].免疫学杂志,2006,22(1):114-115. 被引量:15
  • 2易勤,张谊芝,张敏.生殖器疱疹患者氧化应激与细胞免疫状态的研究[J].四川大学学报(医学版),2006,37(1):150-151. 被引量:8
  • 3Emmert DH.Treatment of common herpes simplex virus infections[J].AM Fam Physicion,2000,61(6):1697-1706,1708.
  • 4Corey L, Wald A, Patel R, et al. Once-daily valacyclovir toreduce the risk of transmission of genital herpes [J].N Engl J Med, 2004, 350 (1): 11-20.
  • 5Eriksson K, Bellner L, Gorander S, et al. CD4 T-cell responses to herpes simplex virus type2 (HSV) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV2 infected individual[J].J Gen Virol, 2004,85 (ptS) 2139 2145.
  • 6Tara S, Johnston C, Huang ML, et al. Overlapping reaction of herpes simplex virus type2 in the genital and perianal mucosa[J].J Infect Dis[J]. 2011,201(4):499 504.
  • 7Corey L, Wald A. Maternal and neonatal herpes simplex virusinfection[J]. N EnglJ Med,2009,361(14):1376-1385.
  • 8I.ong BR, Erickson AE, Chapman JM, et al. Increased number and function of natural killer cells in human immunodefi ciency virus positive subjects co-infection with herpes simpfex virus 2[J]. Immunology, 2010,129(2):186-196.
  • 9Gardella C, Brown Z. Prevention of neonatal herpes [J]. BJOG,201q, 118(2) :187-192.
  • 10Looker K J, Garnelt (;P, Sehmid (;P. An estimale of the global prevalence and incidence of herpes simplex virus type 2 infection I J ]. Bull World Health Organ, 2008, 86(10) : 805-812.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部